Analysts see an interesting path ahead for Gilead Sciences, Inc. (NASDAQ:GILD), between exciting collaborative possibilities and its pipeline catalysts that have brought bullish …
By Sarah Roden Gilead Sciences (NASDAQ: GILD) released first quarter 2015 earnings on April 30. High revenues pointed to the success of Gilead’s …
